Investigators assessed whether PPI therapy is associated with decreased remission rates and increased hospitalizations among patients with IBD receiving infliximab.
Investigators sought to identify oral clinical manifestations due to oral mucosa changes associated with IBD among patients with spondyloarthritis without a diagnosis of IBD.
Investigators assessed disparities in the care and disease education needs of patients with Crohn’s perianal fistulas.
Investigators assessed rates of psychiatric comorbidities and suicide, as well as their risk factors, in patients with childhood-onset immune-mediated inflammatory diseases.
Researchers assessed associations between urgency in patients with ulcerative colitis and quality of life domains, future hospitalizations, steroid prescriptions, and colectomy.
Investigators reported long-term findings on the efficacy of treatment with ozanimod vs placebo in North American patients with moderate to severe ulcerative colitis.
Investigators assessed rates of symptoms of distress in parents of children with inflammatory bowel diseases and how the rates change over the child’s disease course.
Investigators assessed the incidence and clinical characteristics of liver diseases among patients with inflammatory bowel disease.
Researchers assessed the impact of inflammatory bowel disease on the perception of sleep quality.
Investigators assessed the safety and efficacy of vagal nerve stimulation for reducing disease activity and fecal calprotectin levels in children with IBD.
Investigators assessed the impact of prior exposure to biologics on the efficacy of treatment with ozanimod for patients with moderate to severe ulcerative colitis.
Researchers evaluated the performance of the ACE index in predicting steroid response among patients admitted with acute severe ulcerative colitis.
Researchers examined a safe and evidence-based approach to effectively manage pain in patients with IBD flares presenting to the emergency department.
Investigators assessed demographics and treatment patterns among patients with inflammatory bowel disease being treated with vedolizumab.
Investigators assessed whether vedolizumab use is associated with an increased risk for Clostridioides difficile infection vs anti-TNF-α agents in patients with ulcerative colitis.
Investigators assessed the association between processed meat consumption and risk for mortality among patients with inflammatory bowel disease.
Investigators assessed factors associated with a diagnosis of cannabis use disorder among patients hospitalized with IBD, and how this diagnosis affects length of stay.
Researchers sought to evaluate the link between brain fog and probiotic use in patients with inflammatory bowel disease.
Researchers assessed diagnostic benefits of double balloon enteroscopy and its implications in managing patients with known and suspected/rule-out Crohn disease.
Investigators assessed the efficacy and clinical effects of ustekinumab in patients with Crohn disease who had a previously failed anti-TNF therapy attempt.